has announced that the NYSE American has granted it a listing extension until June ... equity of $6.0 million or more to meet requirements. During this period, Hyperscale Data will be subject ...

Company receives approval for Nasdaq or NYSE listing after Beijing’s pledge to help more mainland companies raise funds.

ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology ...

HashKey Group has announced that it has appointed Chagri Poyraz as Chief Risk Officer, who will oversee the firm’s risk ...

American Strategic Investment Co. (NYSE: NYC) ("ASIC" or the "Company") announced today it will release its financial results as of, and for the fourth quarter and year ended December 31, 2024, on ...

Stock splits not only make a company's stock more affordable, but can also cue investors in to competitively advantaged ...

Leading global professional services firm Alvarez & Marsal (A&M) announces the appointment of Jay Frankl as a Managing Director to lead the firm’s newly established Shareholder Activism and Contested ...

Such forward-looking statements in this news release include, but are not limited to, statements regarding the Company’s plans to pursue a listing on a senior national securities exchange in the ...

International stock quotes are delayed as per exchange requirements ... most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.

International stock quotes are delayed as per exchange requirements ... most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.

ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working ...

When finalizing proxy materials for annual shareholder meetings, we recommend that companies consider the recent changes to proxy ...